64 filings
Page 3 of 4
6-K
h5t vdp7wasau9ir
29 Jul 22
Investor Presentation July 2022
4:30pm
6-K
73epkfypfvu94gy
17 May 22
PainReform Provides Business Update for the First Quarter of 2022
7:52am
6-K
m6vasqkzbqpbpa7e4
16 May 22
Condensed Financial Statements
4:31pm
6-K
4blcl
17 Mar 22
PainReform Provides Year-End Business Update; On track to Commence Phase 3 Trial of
8:31am
6-K
j1r fc4a24703ac
9 Dec 21
Current report (foreign)
4:30pm
6-K
b3ei 4po17
16 Nov 21
PainReform Provides Business Update for the Third Quarter of 2021
8:24am
6-K
uku6l2wlnnh
15 Nov 21
Condensed Financial Statements
4:15pm
6-K
hv1t2p9ovo 5u4uoe
27 Oct 21
Annual General Meeting of Shareholders to Be
4:40pm
6-K
2yud h2ak9e50
25 Oct 21
Current report (foreign)
4:30pm
6-K
z2pfre6ym 40c6r
16 Aug 21
Current report (foreign)
8:17am
6-K
fh5xvvx82 pt15dpipo0
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
6-K
tda1hn 5gq
18 Mar 21
PainReform Provides Year-End Business Update and Reports Progress Towards
10:36am
6-K
fssbihpn2glkrb3yvhr
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
dsud6tcx7 cnup
1 Mar 21
Report of Foreign Private Issuer
7:00am
6-K
i8sfjz
23 Feb 21
Report of Foreign Private Issuer
4:30pm
6-K
u04lb6w
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
beb k03a3h5733zqls
6 Jan 21
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
9:00am
6-K
g2v4tbnt8d9qv
5 Jan 21
Investor Presentation January 2021
4:15pm
6-K
cq21eod s6ykj9
4 Jan 21
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
4:16pm
6-K
lav20
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am